These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 28380322)

  • 1. Vitamin D in amyotrophic lateral sclerosis.
    Libonati L; Onesti E; Gori MC; Ceccanti M; Cambieri C; Fabbri A; Frasca V; Inghilleri M
    Funct Neurol; 2017; 32(1):35-40. PubMed ID: 28380322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D deficiency and its supplementation in patients with amyotrophic lateral sclerosis.
    Karam C; Barrett MJ; Imperato T; MacGowan DJ; Scelsa S
    J Clin Neurosci; 2013 Nov; 20(11):1550-3. PubMed ID: 23815870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin D is Not a Protective Factor in ALS.
    Blasco H; Madji Hounoum B; Dufour-Rainfray D; Patin F; Maillot F; Beltran S; Gordon PH; Andres CR; Corcia P
    CNS Neurosci Ther; 2015 Aug; 21(8):651-6. PubMed ID: 26096806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D levels are associated with gross motor function in amyotrophic lateral sclerosis.
    Paganoni S; Macklin EA; Karam C; Yu H; Gonterman F; Fetterman KA; Cudkowicz M; Berry J; Wills AM
    Muscle Nerve; 2017 Oct; 56(4):726-731. PubMed ID: 28044349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D supplementation has no effects on progression of motor dysfunction in amyotrophic lateral sclerosis (ALS).
    Trojsi F; Siciliano M; Passaniti C; Bisecco A; Russo A; Lavorgna L; Esposito S; Ricciardi D; Monsurrò MR; Tedeschi G; Santangelo G
    Eur J Clin Nutr; 2020 Jan; 74(1):167-175. PubMed ID: 31197218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of cystatin C levels in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    Ren Y; Zhu W; Cui F; Yang F; Chen Z; Ling L; Huang X
    Int J Clin Exp Pathol; 2015; 8(5):5419-26. PubMed ID: 26191245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Revised amyotrophic lateral sclerosis functional rating scale at time of diagnosis predicts survival time in amyotrophic lateral sclerosis].
    Liu XX; Fan DS; Zhang J; Zhang S; Zheng JY
    Zhonghua Yi Xue Za Zhi; 2009 Sep; 89(35):2472-5. PubMed ID: 20137433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Six-Minute Walk Test as a Measure of Walking Capacity in Ambulatory Individuals With Amyotrophic Lateral Sclerosis.
    Sanjak M; Langford V; Holsten S; Rozario N; Patterson CGM; Bravver E; Bockenek WL; Brooks BR
    Arch Phys Med Rehabil; 2017 Nov; 98(11):2301-2307. PubMed ID: 28465220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of slow and forced vital capacities on ability to predict survival in ALS.
    Pinto S; de Carvalho M
    Amyotroph Lateral Scler Frontotemporal Degener; 2017 Nov; 18(7-8):528-533. PubMed ID: 28741375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploratory double-blind, parallel-group, placebo-controlled study of edaravone (MCI-186) in amyotrophic lateral sclerosis (Japan ALS severity classification: Grade 3, requiring assistance for eating, excretion or ambulation).
    WRITING GROUP ON BEHALF OF THE EDARAVONE (MCI-186) ALS 18 STUDY GROUP
    Amyotroph Lateral Scler Frontotemporal Degener; 2017 Oct; 18(sup1):40-48. PubMed ID: 28872915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D levels are not predictors of survival in a clinic population of patients with ALS.
    Yang J; Park JS; Oh KW; Oh SI; Park HM; Kim SH
    J Neurol Sci; 2016 Aug; 367():83-8. PubMed ID: 27423568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Network pharmacology analysis and clinical efficacy of the traditional Chinese medicine Bu-Shen-Jian-Pi. Part 3: Alleviation of hypoxia, muscle-wasting, and modulation of redox functions in amyotrophic lateral sclerosis.
    Li R; Han X; Wang Q; Wang C; Jing W; Zhang H; Wang J; Pan W
    Int J Clin Pharmacol Ther; 2024 Apr; 62(4):169-177. PubMed ID: 38431830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and tolerability of EH301 for amyotrophic lateral sclerosis: a randomized, double-blind, placebo-controlled human pilot study.
    de la Rubia JE; Drehmer E; Platero JL; Benlloch M; Caplliure-Llopis J; Villaron-Casales C; de Bernardo N; AlarcÓn J; Fuente C; Carrera S; Sancho D; GarcÍa-Pardo P; Pascual R; JuÁrez M; Cuerda-Ballester M; Forner A; Sancho-Castillo S; Barrios C; Obrador E; Marchio P; Salvador R; Holmes HE; Dellinger RW; Guarente L; Estrela JM
    Amyotroph Lateral Scler Frontotemporal Degener; 2019 Feb; 20(1-2):115-122. PubMed ID: 30668199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rates of progression of weight and forced vital capacity as relevant measurement to adapt amyotrophic lateral sclerosis management for patient Result of a French multicentre cohort survey.
    Clavelou P; Blanquet M; Peyrol F; Ouchchane L; Gerbaud L
    J Neurol Sci; 2013 Aug; 331(1-2):126-31. PubMed ID: 23809193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plateaus and reversals evaluated by different methods in patients with limb-onset amyotrophic lateral sclerosis.
    Hu N; Shen D; Yang X; Cui L; Liu M
    J Clin Neurosci; 2022 Mar; 97():93-98. PubMed ID: 35074582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurofilament Subunit L Levels in the Cerebrospinal Fluid and Serum of Patients with Amyotrophic Lateral Sclerosis.
    Gong ZY; Lv GP; Gao LN; Lu Y; Guo J; Zang DW
    Neurodegener Dis; 2018; 18(2-3):165-172. PubMed ID: 29898446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Creatine for amyotrophic lateral sclerosis/motor neuron disease.
    Pastula DM; Moore DH; Bedlack RS
    Cochrane Database Syst Rev; 2010 Jun; (6):CD005225. PubMed ID: 20556761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of factors that modify susceptibility and rate of progression in amyotrophic lateral sclerosis (ALS).
    Qureshi MM; Hayden D; Urbinelli L; Ferrante K; Newhall K; Myers D; Hilgenberg S; Smart R; Brown RH; Cudkowicz ME
    Amyotroph Lateral Scler; 2006 Sep; 7(3):173-82. PubMed ID: 16963407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of early introduction of non-invasive positive pressure ventilation based on forced vital capacity rate of change: Variation across amyotrophic lateral sclerosis clinical phenotypes.
    Elamin EM; Wilson CS; Sriaroon C; Crudup B; Pothen S; Kang YC; White KT; Anderson WM
    Int J Clin Pract; 2019 Jan; 73(1):e13257. PubMed ID: 30230161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is There a Role for Vitamin D in Amyotrophic Lateral Sclerosis? A Systematic Review and Meta-Analysis.
    Lanznaster D; Bejan-Angoulvant T; Gandía J; Blasco H; Corcia P
    Front Neurol; 2020; 11():697. PubMed ID: 32849187
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.